Aigen Investment Management, LP Moderna, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$101.21 - $166.61 $249,988 - $411,526	2,470 New	2,470 $293,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $2.32 Million - $3.15 Million	19,608 New	19,608 $2.38 Million
Q1 2022 May 05, 2022	SELL	$126.46 - $235.05 $2.19 Million - $4.07 Million	-17,335 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $3.91 Million - $6.39 Million	17,335 New	17,335 $4.85 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $1.07 Million - $1.94 Million	-8,270 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $902,918 - $1.54 Million	8,270 New	8,270 $1.08 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.